ImmunoTherapyNews.net

Cancer immunotherapy

XagenaNewsletter
Xagena Mappa
Medical Meeting
Neurobase.it

Search results for "Merkel cell carcinoma"

Merkel cell carcinoma ( MCC ) is a rare, aggressive skin cancer associated with poor survival outcomes in patients with distant metastatic disease ( mMCC ). In an initial analysis from JAVELIN Mer ...


Recently, it was reported a 56% objective response rate in patients with advanced Merkel cell carcinoma ( MCC ) receiving Pembrolizumab ( Keytruda ). However, a biomarker predicting clinical respons ...